Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2016

Ausgabe 1/2016

Inhaltsverzeichnis ( 24 Artikel )

01.02.2016 | Preclinical Study | Ausgabe 1/2016

Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

Alberto Ocaña, Javier Pérez-Peña, Laura Díez-González, Verónica Sánchez-Corrales, Arnoud Templeton, Bostjan Seruga, Eitan Amir, Atanasio Pandiella

01.02.2016 | Preclinical study | Ausgabe 1/2016

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts

Mohammed A. Aleskandarany, Devika Agarwal, Ola H. Negm, Graham Ball, Ahmed Elmouna, Ibraheem Ashankyty, Edem Nuglozeh, Mohammad F. Fazaludeen, Maria Diez-Rodriguez, Christopher C. Nolan, Patrick J. Tighe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha

01.02.2016 | Preclinical Study | Ausgabe 1/2016

Whole exome sequencing of rare aggressive breast cancer histologies

Maria Vittoria Dieci, Veronika Smutná, Véronique Scott, Guangliang Yin, Ran Xu, Philippe Vielh, Marie-Christine Mathieu, Cécile Vicier, Melanie Laporte, Francoise Drusch, Valentina Guarneri, Pierfranco Conte, Suzette Delaloge, Ludovic Lacroix, Olivia Fromigué, Fabrice André, Celine Lefebvre

01.02.2016 | Preclinical study | Ausgabe 1/2016 Open Access

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

Sanja B. Turturro, Matthew S. Najor, Carl E. Ruby, Melody A. Cobleigh, Abde M. Abukhdeir

01.02.2016 | Preclinical study | Ausgabe 1/2016

Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas

Mayu Takagi, Yasuhiro Miki, Minoru Miyashita, Shuko Hata, Tomomi Yoda, Hisashi Hirakawa, Yasuaki Sagara, Yoshiaki Rai, Yasuyo Ohi, Kentaro Tamaki, Takanori Ishida, Takashi Suzuki, Noriaki Ouchi, Hironobu Sasano

01.02.2016 | Preclinical study | Ausgabe 1/2016 Open Access

Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells

Indira Pandiri, Yingqing Chen, Yeonsoo Joe, Hyo Jeong Kim, Jeongmin Park, Hun Taeg Chung, Jeong Woo Park

01.02.2016 | Preclinical Study | Ausgabe 1/2016

MSCs and inflammation: new insights into the potential association between ALCL and breast implants

M. Orciani, G. Sorgentoni, M. Torresetti, Roberto Di Primio, G. Di Benedetto

01.02.2016 | Clinical trial | Ausgabe 1/2016

A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer

Dimitrios Dionyssiou, Efterpi Demiri, Antonis Tsimponis, Alexandros Sarafis, Vasillios Mpalaris, Georgia Tatsidou, Georgios Arsos

01.02.2016 | Clinical trial | Ausgabe 1/2016 Open Access

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

Miguel Martin, Jan C. Brase, Amparo Ruiz, Aleix Prat, Ralf Kronenwett, Lourdes Calvo, Christoph Petry, Philip S. Bernard, Manuel Ruiz-Borrego, Karsten E. Weber, César A. Rodriguez, Isabel M. Alvarez, Miguel A. Segui, Charles M. Perou, Maribel Casas, Eva Carrasco, Rosalía Caballero, Alvaro Rodriguez-Lescure

01.02.2016 | Clinical trial | Ausgabe 1/2016

Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score

Andreas D. Hartkopf, Markus Wallwiener, Stefan Kommoss, Florin-Andrei Taran, Sara Y. Brucker

01.02.2016 | Clinical trial | Ausgabe 1/2016 Open Access

Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial

A. Welt, N. Marschner, C. Lerchenmueller, T. Decker, C.-C. Steffens, A. Koehler, R. Depenbusch, S. Busies, S. Hegewisch-Becker

01.02.2016 | Clinical trial | Ausgabe 1/2016

Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium

Emily F. Conant, Elisabeth F. Beaber, Brian L. Sprague, Sally D. Herschorn, Donald L. Weaver, Tracy Onega, Anna N. A. Tosteson, Anne Marie McCarthy, Steven P. Poplack, Jennifer S. Haas, Katrina Armstrong, Mitchell D. Schnall, William E. Barlow

01.02.2016 | Clinical trial | Ausgabe 1/2016

A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer

T. Zhu, C. L. Liu, Y. F. Zhang, Y. H. Liu, F. P. Xu, J. Zu, G. C. Zhang, X. R. Li, N. Liao, K. Wang

01.02.2016 | Clinical trial | Ausgabe 1/2016 Open Access

Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

Minish M. Jain, Smita U. Gupte, Shekhar G. Patil, Anand B. Pathak, Chetan D. Deshmukh, Niraj Bhatt, Chiramana Haritha, K. Govind Babu, Shailesh A. Bondarde, Raghunadharao Digumarti, Jyoti Bajpai, Ravi Kumar, Ashish V. Bakshi, Gouri Sankar Bhattacharya, Poonam Patil, Sundaram Subramanian, Ashok K. Vaid, Chirag J. Desai, Ajay Khopade, Geetanjali Chimote, Poonamalle P. Bapsy, Shravanti Bhowmik

01.02.2016 | Clinical trial | Ausgabe 1/2016

Lin28A and androgen receptor expression in ER−/Her2+ breast cancer

Honghong Shen, Yong Yang, Lin Zhao, Jinyang Yuan, Yun Niu

01.02.2016 | Epidemiology | Ausgabe 1/2016

Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis

Jieqiong Liu, Huishan Guo, Kai Mao, Kan Zhang, Heran Deng, Qiang Liu

01.02.2016 | Epidemiology | Ausgabe 1/2016

Childhood body mass index and adult mammographic density measures that predict breast cancer risk

John L. Hopper, Tuong L. Nguyen, Jennifer Stone, Kelly Aujard, Melanie C. Matheson, Michael J. Abramson, John A. Burgess, E. Haydn Walters, Gillian S. Dite, Minh Bui, Christopher Evans, Enes Makalic, Daniel F. Schmidt, Gail Ward, Mark A. Jenkins, Graham G. Giles, Shyamali C. Dharmage, Carmel Apicella

01.02.2016 | Epidemiology | Ausgabe 1/2016 Open Access

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management

Ian M. Collins, Adrian Bickerstaffe, Thilina Ranaweera, Sanjaya Maddumarachchi, Louise Keogh, Jon Emery, G. Bruce Mann, Phyllis Butow, Prue Weideman, Emma Steel, Alison Trainer, Mathias Bressel, John L. Hopper, Jack Cuzick, Antonis C. Antoniou, Kelly-Anne Phillips

01.02.2016 | Epidemiology | Ausgabe 1/2016

DNA methylation modifies the association between obesity and survival after breast cancer diagnosis

Lauren E. McCullough, Jia Chen, Yoon Hee Cho, Nikhil K. Khankari, Patrick T. Bradshaw, Alexandra J. White, Gail Garbowski, Susan L. Teitelbaum, Mary Beth Terry, Alfred I. Neugut, Hanina Hibshoosh, Regina M. Santella, Marilie D. Gammon

01.02.2016 | Epidemiology | Ausgabe 1/2016 Open Access

Study of breast cancer incidence in patients of lymphangioleiomyomatosis

Olivier Nuñez, Antonio Román, Simon R. Johnson, Yoshikazu Inoue, Masaki Hirose, Álvaro Casanova, Gorka Ruiz de Garibay, Carmen Herranz, Gema Bueno-Moreno, Jacopo Boni, Francesca Mateo, Anna Petit, Fina Climent, Teresa Soler, August Vidal, José Vicente Sánchez-Mut, Manel Esteller, José Ignacio López, Nadia García, Anna Gumà, Raúl Ortega, María Jesús Plà, Miriam Campos, Emilio Ansótegui, María Molina-Molina, Claudia Valenzuela, Piedad Ussetti, Rosalía Laporta, Julio Ancochea, Antoni Xaubet, Marina Pollán, Miguel Angel Pujana

01.02.2016 | Letter to the Editor | Ausgabe 1/2016

Comments on ‘Brief screening of patients with distressing fear of recurrence in breast cancer survivors’ by Akechi et al., Breast Cancer Res Treat, 2015, 153(2): pp. 475–476

B. Thewes, M. van de Wal, J. Prins

01.02.2016 | Rebuttal Letter | Ausgabe 1/2016

Author reply: Brief screening of breast cancer survivors with distressing fear of recurrence

Tatsuo Akechi, Kanae Momino, Hiroji Iwata

01.02.2016 | Erratum | Ausgabe 1/2016

Erratum to: JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3

Liliang Li, Pan Gao, Yuhua Li, Yiwen Shen, Jianhui Xie, Daming Sun, Aimin Xue, Ziqin Zhao, Zude Xu, Mingchang Zhang, Beixu Li, Jieqing Jiang

01.02.2016 | Erratum | Ausgabe 1/2016

Erratum to: Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

Elke Ziegler, Marie-Therese Hansen, Maike Haase, Günter Emons, Carsten Gründker

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise